Ludwig researchers describe how acidity turns oxygen-starved cancer cells dormant and drug resistant—and a potentially easy way reverse the effect.
A Ludwig Cancer Research study has uncovered an entirely novel mechanism by which cells enter a state of dormancy as tissues starved of oxygen become increasingly acidic. The study, led by Chi Van Dang, scientific director of the Ludwig Institute for Cancer Research, has potentially significant implications for cancer therapy: Large swaths of solid tumors are often deprived of oxygen, and cells in such patches are thought to be a major source of drug resistance and disease relapses.
Published today in the journal Cell, the study details how in response to acidity cells turn off a critical molecular switch known as mTORC1 that, in ordinary conditions, gauges the availability of nutrients before giving cells the green light to grow and divide. That event, Dang and his colleagues show, shuts down the cell’s production of proteins, disrupting their metabolic activity and circadian clocks, and pushing them into a quiescent state. They also demonstrate that this acid-mediated effect might be relatively easy to reverse—a finding that could help improve a variety of cancer therapies.
“In tumors grafted into mice, we see mTOR activity in spotty places where there’s oxygen,” says Dang who is also a professor in the Molecular and Cellular Oncogenesis Program at The Wistar Institute. “But if you add baking soda to the drinking water given to those mice, the entire tumor lights up with mTOR activity. The prediction would be that by reawakening these cells, you could make the tumor far more sensitive to therapy.”
Baking soda had previously been reported to enhance cancer immunotherapy by one of the co-authors of the new study, Robert Gillies of the H. Lee Moffitt Cancer Center, though the mechanism underlying the effect was unclear.
Dang’s team, including co-corresponding author Zandra Walton, an MD-PhD student at the University of Pennsylvania Perelman School of Medicine, discovered that mechanism through an intricate series of experiments done at the University of Pennsylvania and Dang’s Ludwig lab at the Wistar Institute. It centers on the behavior of lysosomes—a sack-like cellular organelle that digests proteins and that mTOR moves to when it is ready for action.
The researchers show that in acidic conditions protein motors propel lysosomes carrying mTOR away from the area around the nucleus, where they’re ordinarily located. This separates mTOR from a protein required for its activation, RHEB, which continues to hang around at that location. Lacking one of its key activation signals, mTOR remains dormant, suspending the synthesis of proteins—including the components of the cell’s molecular clock—along with most metabolic activity.
“Cells don’t want to make proteins or other biomolecules when they’re under stress,” says Dang. “They want to slow things down and only awaken when things return to normal.”
The researchers show that baking soda can reverse this effect. When given to mice in their drinking water, it surprisingly sufficed to neutralize the acidity of hypoxic patches in tumors. This sent lysosomes zipping back to the nuclear periphery in cells—where RHEB was waiting—and restored the activity of mTOR.
All this is relevant to cancer because researchers have long known that quiescent cells cannot typically be killed by chemotherapy. Notably, Dang and his team also found that T cell activation, which is essential to most immunotherapies, is similarly compromised under acidic conditions.
“We started out with a question about oxygen starvation and the circadian clock, and we ended up discovering a new mechanism by which acidic conditions in tissues shut off a lot of things—including the cell’s molecular clock,” muses Dang.
The finding that something as simple as baking soda could possibly help reverse this effect and render quiescent cancer cells susceptible to cancer therapies excites Dang.
“The concept is so easy,” he says. “It’s not some $100,000 per year drug. It’s literally just baking soda.” Dang and his team are now looking into how acidity might affect immunotherapy and further exploring the acid-induced quiescence of cancer cells.
Learn more: HOW MIGHT BAKING SODA BOOST CANCER THERAPY?
The Latest on: Cancer therapy
[google_news title=”” keyword=”cancer therapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer therapy
- Racial, Ethnic Differences Seen in Breast Cancer Treatment Declinationon May 9, 2024 at 11:30 pm
For patients with breast cancer, there are racial and ethnic differences in treatment declination, according to a study published online May 9 in JAMA Network Open. Jincong Q. Freeman, M.P.H., from ...
- Health News Roundup: Merck's endometrial cancer therapy fails trial; NYC sued for denying gay employees in vitro fertilization coverage and moreon May 9, 2024 at 11:06 pm
Japan's biggest drugmaker said it will incur restructuring costs of about 140 billion yen ($899 million) this fiscal year as part of a plan to optimise its workforce, cut costs and strengthen ...
- Tattoo-Free Radiotherapy: Innovating Cancer Treatment in Shropshireon May 9, 2024 at 10:30 pm
Surface Guided Radiotherapy (SGRT), which delivers targeted treatment using specialist equipment, has been installed within the Radiotherapy department of the ...
- Standard blood cancer treatment reveals positive results in those over 80, study findson May 9, 2024 at 9:12 pm
The standard treatment for acute myeloid leukemia (AML) is safe and effective for adults over 80, a study published Thursday in Blood Neoplasia finds. The treatment can extend survival for about 25% ...
- Hospital is first in WNY to offer noninvasive prostate cancer therapyon May 9, 2024 at 1:00 pm
Administered using advanced robotics, the treatment offers a new option for men who previously were candidates only for active surveillance.
- Merck's endometrial cancer therapy fails trialon May 9, 2024 at 8:54 am
Merck said on Thursday its therapy did not meet the main goal of disease-free survival in certain patients with endometrial cancer during a late-stage trial.
- Cancer: Here's the role exercise plays, from prevention to treatmenton May 9, 2024 at 8:48 am
Cancer is the second leading cause of death worldwide. In Europe, almost 3 in every 10 adults were diagnosed with a form of cancer in 2022.
- I Had Cancer. My Treatment Was Eye-Opening About Addictionon May 9, 2024 at 6:14 am
I've had two different types of cancer in two years and in both instances, I was screened, diagnosed early, and ushered into care.
- King Charles Takes on First Solo Engagement Since Returning to Royal Duties During Cancer Treatmenton May 9, 2024 at 5:46 am
The King has been easing back into his royal duties after Buckingham Palace announced he was undergoing treatment for cancer on Feb. 5. On April 30, he and Queen Camilla, 76, visited the University ...
via Bing News